Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Des chercheurs de l'Institut du Cerveau

Organization of research

Search, Find, Cure

Last update: 08/11/2024 Reading time: 1min

The scientific and medical strategy of Paris Brain Institute is based on a transdisciplinary and synergistic approach combining basic and translational research, clinical expertise and support of advanced technological platforms. This organization enables it to meet the challenges of understanding the nervous system and its diseases and to benefit from a strong international presence, which is becoming increasingly visible.

Ambition

The ambition of Paris Brain Institute

Paris Brain Institute was created to be the home of major discoveries about how the brain works, both in health and disease, and to accelerate innovation for the benefit of patients.

In order to become a leader in the prevention and treatment of diseases of the nervous system, Paris Brain Institute cultivates research excellence in Neuroscience, supported by an effective innovation strategy. With a policy of attracting international talent and the creation of a unique training place open to society and the world.

Strategy

Paris Brain Institute Strategy

By seeking to understand the normal functioning of the nervous system through basic science, Paris Brain Institute's research provides the foundation for understanding neurological and psychiatric disorders, and aims to reduce the impact of these disorders on individuals, their families and society.

Neuroscience is concerned with the functioning of the brain and spinal cord from molecules to cognition, and at multiple intermediate scales. Paris Brain Institute proposes to address brain and spinal cord activities at multiple scales rather than focusing on individual advances reduced to a field. In recent decades, breakthroughs have provided new tools and techniques for observing and even controlling brain activity: the sequencing of the human genome, revolutionary imaging technologies, discoveries in nanosciences and physics, optogenetics, etc. By transcending traditional research boundaries and continuing its efforts in translational research, Paris Brain Institute is positioning itself • catalyzing research on the brain and its diseases, both locally and internationally.

The main challenges facing Paris Brain Institute are:

  1. Deciphering the neural code and understanding the development and functioning of neural networks from the synapse to the brain network.
  2. Discovering the origin of thoughts, behaviour and identity
  3. Address diseases of the nervous system through a basic/translational/clinical research coalition.
  4. Develop a new generation of customized tools/care/treatment for patients with nervous system diseases.

To support the cutting-edge work of its scientists and clinicians, Paris Brain Institute has developed leading-edge technology platforms and efficient facilities, enabling preclinical and clinical exploration of brain structure and function, while fostering translational research.

Clinical research relies heavily on the Centre for Clinical Investigation Neurosciences (CIC) present on site.

Health innovations are also supported by a comprehensive set of clinical research platforms dedicated to neuroscience, from the bench to the bedside, and are translated into applications thanks to the strong support of our technology transfer department, including the start-up incubator.

5 scientific domains

Five major scientific domains

Paris Brain Institute's scientific community is organized around 5 domains that represent the specific approaches of our researchers.

Scientific teams

Scientific teams

Teams represent the Institute's reference research entity. Each team is organized around a research program motivated by a common scientific question. They are led by one or two team leaders - usually a researcher/clinician-researcher pairing - and are made up of investigators (PIs), engineers, research staff and their students. 

A PI (principal investigator) is a permanent scientist on a research team, usually a researcher, teacher-researcher or clinician-researcher. The PI is in charge of a line of research integrated into the team's program. He or she is responsible for supervising the team and obtaining the funding needed to conduct the research. Each PI is attached to one or more major scientific fields. 

Cross-functionnal projects

Cross-functionnal projects

In order to meet the challenges of understanding diseases of the nervous system, Paris Brain Institute has chosen to promote research around cross-functionnal and multidisciplinary research programs. This organisation involves all the researchers of Paris Brain Institute in scientific / technological choices and stimulates collaborations through bold interdisciplinary projects, creating new research interfaces.

News that might interest you

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news